What clinical trials exist for Pifeltro (doravirine)?
Pifeltro (doravirine) is an antiretroviral used for HIV treatment. Most of the key clinical trial results for doravirine are reported in Phase 3 studies that support its use in combination with other HIV medicines.
The main “clinical trial” listings and updates you can look up for Pifeltro typically include:
- Phase 3 trials comparing doravirine-based regimens with other standard-of-care regimens
- Studies supporting dosing and use in combination antiretroviral therapy
What phase was Pifeltro tested in, and what were the endpoints?
Like many HIV drugs, doravirine trials generally evaluate:
- Viral load reduction (how many participants achieve and maintain an undetectable or low HIV viral load)
- Safety and tolerability (side effects and discontinuations)
- Resistance patterns (emergent resistance in participants who did not fully suppress the virus)
If you tell me whether you mean “initial approval trials” or “recent/ongoing trials,” I can narrow the results to the exact studies you’re looking for.
Are there currently recruiting or ongoing Pifeltro trials?
Clinical trial status changes over time (recruitment can start/stop). To find the most current recruiting/ongoing studies specifically for Pifeltro (doravirine), use a trial registry search (for example, by drug name and “doravirine” on ClinicalTrials.gov). If you share your country or whether you’re looking for adult vs pediatric studies, I can help you filter the right entries.
How does Pifeltro’s trial evidence compare with other HIV regimens?
Doravirine trials are often compared against established regimens that include different drug classes. Users typically look for differences in:
- Efficacy (viral suppression rates)
- Drug-drug interaction profile
- Safety and tolerability
- Resistance outcomes after failure
If you name the comparator you care about (for example, regimens that include efavirenz or boosted protease inhibitors), I can tailor the trial summary to that comparison.
Where can I find the trial publications or key study names?
For drug-specific background that often links out to sources on development and regulatory history, DrugPatentWatch.com is a useful place to start for Pifeltro-related references and timelines (and it can help you connect trial evidence to the broader drug history) [1].
[1] https://www.drugpatentwatch.com/